601607 上海医药
已收盘 09-11 15:00:00
资讯
新帖
简况
每周股票复盘：上海医药（601607）盐酸林可霉素通过一致性评价
证券之星 · 02:13
每周股票复盘：上海医药（601607）盐酸林可霉素通过一致性评价
上海医药：每股派0.10元，股权登记日为9月17日
南方财经网 · 09-11 16:52
上海医药：每股派0.10元，股权登记日为9月17日
股市必读：上海医药新发布《上海医药集团股份有限公司2026年半年度权益分派实施公告》
证券之星 · 09-11 01:10
股市必读：上海医药新发布《上海医药集团股份有限公司2026年半年度权益分派实施公告》
上海医药(601607.SH)下属公司盐酸林可霉素注射液通过仿制药一致性评价
智通财经 · 09-10
上海医药(601607.SH)下属公司盐酸林可霉素注射液通过仿制药一致性评价
股市必读：上海医药（601607）9月9日董秘有最新回复
证券之星 · 09-10
股市必读：上海医药（601607）9月9日董秘有最新回复
上海医药：若涉及大股东减持事宜会及时履行信息披露义务
证券之星 · 09-09
上海医药：若涉及大股东减持事宜会及时履行信息披露义务
上海医药与上海药物所达成战略合作
第一财经 · 09-07
上海医药与上海药物所达成战略合作
上海医药：8月28日进行路演，东北证券、中信证券等多家机构参与
证券之星 · 09-07
上海医药：8月28日进行路演，东北证券、中信证券等多家机构参与
上海医药公布2026财年中期权益分配方案
同花顺 · 09-03
上海医药公布2026财年中期权益分配方案
上海医药：八宝丹传统制作技艺入选福建省级非遗代表性项目
证券之星 · 09-02
上海医药：八宝丹传统制作技艺入选福建省级非遗代表性项目
投资收益“断崖式”退潮，上海医药上半年净利润下滑超两成，应收账款逼近千亿元
深圳商报·读创 · 09-02
投资收益“断崖式”退潮，上海医药上半年净利润下滑超两成，应收账款逼近千亿元
股市必读：上海医药新发布《上海医药集团股份有限公司关于磷酸芦可替尼片获得批准生产的公告》
证券之星 · 09-02
股市必读：上海医药新发布《上海医药集团股份有限公司关于磷酸芦可替尼片获得批准生产的公告》
上海医药上半年营收超1400亿元 应收账款规模有所扩张
经济参考网 · 09-01
上海医药上半年营收超1400亿元 应收账款规模有所扩张
上海医药：磷酸芦可替尼片获得批准生产
第一财经 · 08-31
上海医药：磷酸芦可替尼片获得批准生产
每周股票复盘：上海医药（601607）H1营收增4.15%但净利降21.4%
证券之星 · 08-30
每周股票复盘：上海医药（601607）H1营收增4.15%但净利降21.4%
上海医药（601607）2026年中报简析：增收不增利
证券之星 · 08-29
上海医药（601607）2026年中报简析：增收不增利
上海医药（601607）披露2026年半年度利润分配方案，8月27日股价下跌0.91%
证券之星 · 08-27
上海医药（601607）披露2026年半年度利润分配方案，8月27日股价下跌0.91%
上海医药2026年中报：工业创新提速、商业转型增效
中国财富通 · 08-27
上海医药2026年中报：工业创新提速、商业转型增效
上海医药2026年上半年归母净利润同比下降21.4%
北京商报 · 08-27
上海医药2026年上半年归母净利润同比下降21.4%
上海医药(02607)拟挂牌转让上海上药新特东铵大药房51%股权
智通财经网 · 08-24
上海医药(02607)拟挂牌转让上海上药新特东铵大药房51%股权
加载更多
公司概况
公司名称：
上海医药集团股份有限公司
所属行业：
零售业
上市日期：
1994-03-24
主营业务：
上海医药集团股份有限公司的主营业务是医药工业、医药商业。公司的主要产品是药品、医疗器械、大健康产品、医药商业。公司再度入选《财富》世界500强和《PharmExec》2026全球制药企业50强榜单，排名为第411位和第39位。
发行价格：
4.50
{"stockData":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":16.29,"timestamp":1789110000000,"preClose":16.31,"halted":0,"volume":8709270,"delay":0,"changeRate":-0.0012,"floatShares":2789000000,"shares":3708000000,"eps":1.2864,"marketStatus":"已收盘","change":-0.02,"latestTime":"09-11 15:00:00","open":16.3,"high":16.36,"low":16.2,"amount":142000000,"amplitude":0.0098,"askPrice":16.3,"askSize":45,"bidPrice":16.29,"bidSize":19,"shortable":0,"etf":0,"ttmEps":1.2864,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.31,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":17.94,"lowLimit":14.68,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3708361809,"isCdr":false,"pbRate":0.77,"roa":"--","peRate":12.663246,"roe":"4.51%","epsLYR":1.54,"committee":0.481107,"marketValue":60409000000,"turnoverRate":0.0031,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-14。","hkstockBrief":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":11.03,"timestamp":1789114135007,"preClose":11.15,"halted":0,"volume":1899542,"delay":0,"premium":"-42.11"},"floatMarketCap":45436000000},"requestUrl":"/m/hq/s/601607","defaultTab":"news","newsList":[{"id":"2667507911","title":"每周股票复盘：上海医药（601607）盐酸林可霉素通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507911","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667507911?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:13","pubTimestamp":1789236790,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，上海医药报收于16.29元，较上周的16.62元下跌1.99%。公司公告汇总上海医药集团股份有限公司发布2026年半年度权益分派实施公告，本次利润分配经2025年年度股东会审议通过。上海医药集团股份有限公司下属上海禾丰制药有限公司收到国家药品监督管理局颁发的《药品补充申请批准通知书》，盐酸林可霉素注射液通过仿制药质量和疗效一致性评价。2025年7月，上药禾丰提交一致性评价申请并获受理，截至公告日研发投入约197万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0184","BK0175","BK0020","BK0196","BK1197","BK0097","BK0209","601607","02607","BK0183","BK0187","BK0188","BK0012","BK0099","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666823540","title":"上海医药：每股派0.10元，股权登记日为9月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2666823540","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666823540?lang=zh_cn&edition=full","pubTime":"2026-09-11 16:52","pubTimestamp":1789116720,"startTime":"0","endTime":"0","summary":"南财智讯9月11日电，上海医药发布2026年半年度权益分派实施公告，每股派0.10元（含税），股权登记日为9月17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609113872118437.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609113872118437.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0020","BK0187","BK0209","BK0028","BK0099","BK0188","02607","BK0012","BK0097","BK0196","601607","BK0184","BK0175","BK1197","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666974865","title":"股市必读：上海医药新发布《上海医药集团股份有限公司2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666974865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666974865?lang=zh_cn&edition=full","pubTime":"2026-09-11 01:10","pubTimestamp":1789060222,"startTime":"0","endTime":"0","summary":"公司公告汇总：上海医药下属上海禾丰制药有限公司盐酸林可霉素注射液通过仿制药一致性评价，2025年该药品中国大陆医院采购金额为2168万元，截至公告日研发投入约197万元。公司公告汇总上海医药集团股份有限公司2026年半年度权益分派实施公告本次利润分配经2026年6月25日召开的2025年年度股东会审议通过，每股派发现金红利0.10元（含税），以公司总股本3,708,361,809股为基数，共计派发现金红利370,836,180.90元，其中A股现金红利278,928,910.50元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0020","BK0188","BK0028","BK0196","BK0099","BK0175","BK0187","BK0184","02607","BK0012","601607","BK0209","BK0183","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666567287","title":"上海医药(601607.SH)下属公司盐酸林可霉素注射液通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2666567287","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666567287?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:53","pubTimestamp":1789037606,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属上海禾丰制药有限公司收到国家药品监督管理局颁发的关于盐酸林可霉素注射液的《药品补充申请批准通知书》，该药品通过仿制药一致性评价。该药品适用于由链球菌、肺炎球菌和葡萄球菌等敏感菌株引起的严重感染，但仅适用于对青霉素过敏的患者或经医生判断不宜使用青霉素的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0209","BK1197","BK0099","BK0196","BK0097","BK0020","BK0012","BK0188","BK0028","BK0187","BK0175","BK0183","BK0184","601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666532844","title":"股市必读：上海医药（601607）9月9日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2666532844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666532844?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:32","pubTimestamp":1788975135,"startTime":"0","endTime":"0","summary":"截至2026年9月9日收盘，上海医药报收于16.48元，下跌0.54%，换手率0.2%，成交量5.63万手，成交额9282.21万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000002038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK1197","BK0099","BK0196","BK0097","BK0020","BK0012","BK0188","BK0028","BK0187","BK0175","BK0183","BK0184","601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666581029","title":"上海医药：若涉及大股东减持事宜会及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2666581029","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666581029?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:57","pubTimestamp":1788947825,"startTime":"0","endTime":"0","summary":"证券之星消息，上海医药(601607)09月09日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，云南白药的36个月的减持期已经结束，该公司是否考虑减持公司股票？上海医药回复：尊敬的投资者您好，若涉及大股东减持事宜，公司会按照监管规则的要求及时履行相应的信息披露义务。目前题述一事暂未涉及，感谢您的关注。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900030720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0020","BK0187","BK0209","BK0028","BK0099","BK0188","02607","BK0012","BK0097","BK0196","601607","BK0184","BK0175","BK1197","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665312645","title":"上海医药与上海药物所达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2665312645","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665312645?lang=zh_cn&edition=full","pubTime":"2026-09-07 21:51","pubTimestamp":1788789109,"startTime":"0","endTime":"0","summary":"【上海医药与上海药物所达成战略合作】上海医药消息，9月7日，上海医药集团股份有限公司与中国科学院上海药物研究所签署合作框架协议。双方将围绕创新药物研发及成果转化开展深度合作，进一步推动科研端与产业端优势衔接，共同提升创新成果转化效率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866983664.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866983664.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0099","BK0196","BK0020","BK0012","BK0184","BK1197","BK0209","BK0188","BK0028","BK0187","BK0097","BK0175","02607","601607","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665731171","title":"上海医药：8月28日进行路演，东北证券、中信证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2665731171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665731171?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:44","pubTimestamp":1788774272,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年9月2日上海医药发布公告称公司于2026年8月28日进行路演，东北证券、中信证券、中金公司、中信建投、兴业证券、西南证券、中邮证券、仁桥资产、中欧基金参与。截至6月底，B007重症肌无力适应症II期临床试验已完成全部受试者出组和临床总结报告定稿。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1516","BK0099","BK0188","LU1328615791.USD","LU2580892789.USD","LU1997245177.USD","LU0405327494.USD","LU0405327148.USD","BK0097","LU1997245094.SGD","LU1794554557.SGD","LU2148510915.USD","BK0012","LU1255011170.USD","06030","LU1146622755.USD","BK0196","BK0020","BK0183","02607","BK1564","LU1580142542.USD","BK0175","BK1521","BK1197","LU1781817850.SGD","BK0184","BK0276","BK0187","LU2495084118.USD","BK1147","LU1064130708.USD","LU1820825898.SGD","000686","601607","LU2289578879.USD","BK0028","BK0209","LU2580892862.HKD","LU1720050803.USD","LU1064131003.USD","600030","LU1997244956.HKD","LU1655091616.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664876257","title":"上海医药公布2026财年中期权益分配方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2664876257","media":"同花顺","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664876257?lang=zh_cn&edition=full","pubTime":"2026-09-03 18:50","pubTimestamp":1788432600,"startTime":"0","endTime":"0","summary":"上海医药（HK02607）9月3日发布公告，公司将于2026年10月23日一般分红每股0.11663港元 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20260903/c679574366.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260903/c679574366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0020","BK0187","BK0209","BK0099","601607","BK0012","BK0175","BK0183","BK0184","BK0196","BK0028","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664989086","title":"上海医药：八宝丹传统制作技艺入选福建省级非遗代表性项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2664989086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664989086?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:12","pubTimestamp":1788340334,"startTime":"0","endTime":"0","summary":"证券之星消息，上海医药09月02日在投资者关系平台上答复投资者关心的问题。拥有“鼎炉”中华老字号、多项省市级非物质文化遗产、中国驰名商标等资质。上药厦中所传承的八宝丹传统制作技艺，于今年入选福建省级非遗代表性项目。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607","BK0012","BK0097","BK0099","BK0187","BK1197","BK0020","BK0175","BK0209","BK0188","BK0184","BK0196","BK0028","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980368","title":"投资收益“断崖式”退潮，上海医药上半年净利润下滑超两成，应收账款逼近千亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980368","media":"深圳商报·读创","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664980368?lang=zh_cn&edition=full","pubTime":"2026-09-02 10:52","pubTimestamp":1788317531,"startTime":"0","endTime":"0","summary":"深圳商报·读创客户端记者张弛近日，上海医药集团股份有限公司（601607.SH/02607.HK）披露的2026年半年度报告显示，公司上半年实现营业收入1474.70亿元，同比增长4.15%；实现归属于上市公司股东的净利润35.04亿元，同比下降21.40%；基本每股收益0.95元，同比下降20.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609023862592729.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609023862592729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664686315","title":"股市必读：上海医药新发布《上海医药集团股份有限公司关于磷酸芦可替尼片获得批准生产的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664686315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664686315?lang=zh_cn&edition=full","pubTime":"2026-09-02 01:40","pubTimestamp":1788284423,"startTime":"0","endTime":"0","summary":"公司公告汇总：上海医药下属常州制药厂有限公司磷酸芦可替尼片获国家药监局批准生产，系国内第二家获批企业，此前仅诺华在境内供应；2025年该药国内医院采购额达7.168亿元。公司公告汇总上海医药集团股份有限公司关于磷酸芦可替尼片获得批准生产的公告上海医药集团股份有限公司下属常州制药厂有限公司收到国家药品监督管理局颁发的《药品注册证书》，磷酸芦可替尼片获得批准生产。中国境内此前仅有瑞士诺华制药生产该药品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200001987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","601607","BK0099","BK0183","BK0184","02607","BK0020","BK0012","BK0188","BK0209","BK1197","BK0175","BK0028","BK0097","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664546854","title":"上海医药上半年营收超1400亿元 应收账款规模有所扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=2664546854","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664546854?lang=zh_cn&edition=full","pubTime":"2026-09-01 21:26","pubTimestamp":1788269162,"startTime":"0","endTime":"0","summary":"近日，上海医药（601607.SH）披露2026年半年报。在医药流通行业整体仍处于调整期的背景下，公司扣非归母净利润实现两位数增长，主业盈利韧性凸显，公司应收账款规模随业务拓展有所扩张，资产质量与运营效率的平衡成为新课题。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609013861720732.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609013861720732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663207390","title":"上海医药：磷酸芦可替尼片获得批准生产","url":"https://stock-news.laohu8.com/highlight/detail?id=2663207390","media":"第一财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663207390?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:10","pubTimestamp":1788163841,"startTime":"0","endTime":"0","summary":"【上海医药：磷酸芦可替尼片获得批准生产】上海医药公告，近日，公司下属常州制药厂有限公司收到国家药品监督管理局颁发的关于磷酸芦可替尼片的《药品注册证书》，该药品获得批准生产。磷酸芦可替尼片适用于骨髓纤维化、移植物抗宿主病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313860097178.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313860097178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0209","BK1197","601607","BK0099","BK0188","BK0196","BK0012","02607","BK0175","BK0020","BK0028","BK0183","BK0184","BK0187","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663439190","title":"每周股票复盘：上海医药（601607）H1营收增4.15%但净利降21.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663439190","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663439190?lang=zh_cn&edition=full","pubTime":"2026-08-30 07:49","pubTimestamp":1788047349,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，上海医药报收于16.41元，较上周的16.19元上涨1.36%。本周，上海医药8月26日盘中最高价报16.59元。本周关注点业绩披露要点：上海医药2026年上半年主营收入1474.7亿元，同比上升4.15%；归母净利润35.04亿元，同比下降21.4%。第二季度单季主营收入722.08亿元，同比上升1.95%；单季度归母净利润20.87亿元，同比下降33.24%；单季度扣非净利润12.39亿元，同比上升48.17%。上海医药对上海上实集团财务有限公司截至2026年6月30日的风险状况进行评估。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016306","title":"上海医药（601607）2026年中报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016306?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:06","pubTimestamp":1787954805,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期上海医药发布2026年中报。根据财报显示，上海医药增收不增利。截至本报告期末，公司营业总收入1474.7亿元，同比上升4.15%，归母净利润35.04亿元，同比下降21.4%。本文数据来源于上海医药2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900010487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0097","BK0020","BK0188","BK1197","601607","BK0196","BK0183","BK0184","BK0175","BK0099","BK0209","BK0187","BK0012","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662748085","title":"上海医药（601607）披露2026年半年度利润分配方案，8月27日股价下跌0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662748085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662748085?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:18","pubTimestamp":1787840329,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，上海医药报收于16.27元，较前一交易日下跌0.91%，最新总市值为603.35亿元。该股当日开盘16.39元，最高16.46元，最低16.18元，成交额达1.55亿元，换手率为0.34%。近日，上海医药集团股份有限公司召开第九届董事会第四次会议，审议通过《2026年半年度利润分配方案》。董事会授权沈波先生负责实施利润分配相关事宜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700055380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0099","601607","BK0188","BK0020","BK0097","BK0184","BK0209","BK0183","BK0187","BK1197","02607","BK0012","BK0175","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069297","title":"上海医药2026年中报：工业创新提速、商业转型增效","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069297","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069297?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:43","pubTimestamp":1787827421,"startTime":"0","endTime":"0","summary":"截至报告期末，上海医药处于临床申请受理及后续阶段的在研新药管线合计61项，其中创新药49项，形成梯次接续的优质创新管线格局。截至目前，上海医药累计486个品种入选国家基药目录。报告期内，上海医药紧扣数字化转型、创新药商业化、精益化运营三大核心主线，持续优化商业业务结构，各核心板块实现高质量增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=95Tc3N%2F8UZc%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607","BK0175","BK0187","BK0028","BK0184","BK0097","BK0020","BK0188","601607","BK0196","BK0209","BK0183","BK0012","BK1197","BK0099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662706944","title":"上海医药2026年上半年归母净利润同比下降21.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662706944","media":"北京商报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662706944?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:23","pubTimestamp":1787826206,"startTime":"0","endTime":"0","summary":"8月27日，上海医药发布2026年半年度报告。上半年，公司实现营业收入1474.7亿元，同比增长4.15%；归属于上市公司股东的净利润为35.04亿元，同比下降21.4%；归属于上市公司股东的扣除非经常性损益的净利润为24.77亿元，同比增长17.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608273856573872.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608273856573872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661827678","title":"上海医药(02607)拟挂牌转让上海上药新特东铵大药房51%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2661827678","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661827678?lang=zh_cn&edition=full","pubTime":"2026-08-24 20:26","pubTimestamp":1787574401,"startTime":"0","endTime":"0","summary":"上海医药(02607)公布，公司全资子公司上药控股有限公司拟通过产权交易所以公开挂牌方式转让所持控股子公司上海上药新特东铵大药房有限公司(以下简称“标的公司”)51%股权，挂牌转让价格拟定为人民币1.785亿元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggaonew/ganggugongg6.jpg?x-oss-process=image/format,jpg/quality,Q_100/resize,h_300"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02607","BK0175","BK0187","BK0028","BK0184","BK0097","BK0020","BK0188","601607","BK0196","BK0209","BK0183","BK0012","BK1197","BK0099"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789305924133,"stockEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0163},{"period":"3month","weight":0.0179},{"period":"6month","weight":-0.038},{"period":"1year","weight":-0.0845},{"period":"ytd","weight":-0.0624}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"0人","perCapita":"--","listingDate":"1994-03-24","address":"上海市浦东新区中国(上海)自由贸易试验区张江路92号","registeredCapital":"370836万元","survey":" 上海医药集团股份有限公司的主营业务是医药工业、医药商业。公司的主要产品是药品、医疗器械、大健康产品、医药商业。公司再度入选《财富》世界500强和《PharmExec》2026全球制药企业50强榜单，排名为第411位和第39位。","listedPrice":4.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(601607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(601607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,601607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(601607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(601607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}